C. Ola Landgren, Chief of the Division of Myeloma at University of Miami and Leader of Experimental Therapeutics Program at Sylvester Comprehensive Cancer Center, shared a post on X:
“How Quadruplet Therapy Is Changing the Myeloma Treatment Landscape.
Summary of Latest News From ASCO24 Focusing on Newly Diagnosed Myeloma Therapy.
Watch here.”
Source: C. Ola Landgren/X